Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2011 Aug 25:12:201.
doi: 10.1186/1745-6215-12-201.

Between-centre differences and treatment effects in randomized controlled trials: a case study in traumatic brain injury

Hester F Lingsma  1 , Bob Roozenbeek, Pablo Perel, Ian Roberts, Andrew I R Maas, Ewout W Steyerberg
Affiliations
Randomized Controlled Trial

Between-centre differences and treatment effects in randomized controlled trials: a case study in traumatic brain injury

Hester F Lingsma et al. Trials. .

Abstract

Background: In Traumatic Brain Injury (TBI), large between-centre differences in outcome exist and many clinicians believe that such differences influence estimation of the treatment effect in randomized controlled trial (RCTs). The aim of this study was to assess the influence of between-centre differences in outcome on the estimated treatment effect in a large RCT in TBI.

Methods: We used data from the MRC CRASH trial on the efficacy of corticosteroid infusion in patients with TBI. We analyzed the effect of the treatment on 14 day mortality with fixed effect logistic regression. Next we used random effects logistic regression with a random intercept to estimate the treatment effect taking into account between-centre differences in outcome. Between-centre differences in outcome were expressed with a 95% range of odds ratios (OR) for centres compared to the average, based on the variance of the random effects (tau2). A random effects logistic regression model with random slopes was used to allow the treatment effect to vary by centre. The variation in treatment effect between the centres was expressed in a 95% range of the estimated treatment ORs.

Results: In 9978 patients from 237 centres, 14-day mortality was 19.5%. Mortality was higher in the treatment group (OR = 1.22, p = 0.00010). Using a random effects model showed large between-centre differences in outcome (95% range of centre effects: 0.27- 3.71), but did not substantially change the estimated treatment effect (OR = 1.24, p = 0.00003). There was limited, although statistically significant, between-centre variation in the treatment effect (OR = 1.22, 95% treatment OR range: 1.17-1.26).

Conclusion: Large between-centre differences in outcome do not necessarily affect the estimated treatment effect in RCTs, in contrast to current beliefs in the clinical area of TBI.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Differences between centres in mortality, adjusted for age, GCS, pupil reactivity and treatment in a random effects model. A centre with average mortality has log odds 0, a positive log odds indicates higher mortality. Lines indicate 95% posterior interval.
Figure 2
Figure 2
Between-centre differences in treatment effect, in a random effect model. The overall treatment effect is log odds = 0.20 (OR = 1.22). Lines indicate 95% posterior interval.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Maas AI, Stocchetti N, Bullock R. Moderate and severe traumatic brain injury in adults. Lancet Neurol. 2008;7(8):728–41. doi: 10.1016/S1474-4422(08)70164-9. - DOI - PubMed
    1. Finkelstein EA, Corso PS, Miller TR. The incidence and economic burden of injuries in the United States. New York: Oxford University Press; 2006.
    1. Maas AI, Marmarou A, Murray GD, Teasdale SG, Steyerberg EW. Prognosis and clinical trial design in traumatic brain injury: the IMPACT study. J Neurotrauma. 2007;24(2):232–8. doi: 10.1089/neu.2006.0024. - DOI - PubMed
    1. Dickinson K, Bunn F, Wentz R, Edwards P, Roberts I. Size and quality of randomised controlled trials in head injury: review of published studies. BMJ. 2000;320(7245):1308–11. doi: 10.1136/bmj.320.7245.1308. - DOI - PMC - PubMed
    1. Maas AI, Murray G, Henney H, Kassem N, Legrand V, Mangelus M, Muizelaar JP, Stocchetti N, Knoller N. Pharmos TBI investigators. Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial. Lancet Neurol. 2006;5(1):38–45. doi: 10.1016/S1474-4422(05)70253-2. - DOI - PubMed

Publication types

MeSH terms